These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4860027)

  • 1. [Clinical use of Duvadilan for hearing disorders].
    Takayasu S; Katrri S
    Jibiinkoka; 1966 Jul; 38(7):749-54. PubMed ID: 4860027
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tebonin treatment of hearing disorders in the elderly].
    Koeppel FW
    Munch Med Wochenschr; 1970 Nov; 112(46):2091-4. PubMed ID: 5537998
    [No Abstract]   [Full Text] [Related]  

  • 3. Sudden hearing loss: a medical emergency.
    Peisel FJ
    J Ky Med Assoc; 1967 May; 65(5):491-2 passim. PubMed ID: 6042087
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectivity of Cavinton and Lucidril in the treatment of hearing defects of different origin.
    Jasper A
    Ther Hung; 1979; 27(1):29-31. PubMed ID: 386551
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of acute hearing loss or labyrinth prolapse].
    Spoendlin H
    Dtsch Med Wochenschr; 1968 Mar; 93(9):403-5. PubMed ID: 5648355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug treatment of hearing losses (author's transl)].
    Kellerhals B
    Ther Umsch; 1978 Jul; 35(7):572-7. PubMed ID: 684650
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indications of Surheme in otorhinolaryngology. Clinical, audiometric and electronystagmographic study].
    Bertoni R
    Therapeutique; 1971 Nov; 47(9):789-96. PubMed ID: 5147558
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutical results of non-acute perceptive hearing loss with vasoactive medicaments (author's transl)].
    Naujoks J; Hollerbach M; Schulz CE
    Laryngol Rhinol Otol (Stuttg); 1977 Apr; 56(4):363-6. PubMed ID: 140985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinpocetine. Monograph.
    Altern Med Rev; 2002 Jun; 7(3):240-3. PubMed ID: 12126465
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of short-term administration of a vasodilator agent (Duvadilan) in tinnitus. Comparative study by a double-blind test].
    Kamei T
    Jibiinkoka; 1970 Feb; 42(2):153-8. PubMed ID: 4909118
    [No Abstract]   [Full Text] [Related]  

  • 11. [New findings in the treatment of sensorineural hypacusis].
    Chládek V
    Cas Lek Cesk; 1972 Mar; 111(12):271-3. PubMed ID: 4401049
    [No Abstract]   [Full Text] [Related]  

  • 12. [Angiodilatator therapy in otology: value of Praxilene].
    Bordes LR; Baradat P; Lienhart H; Debrie JC
    Rev Laryngol Otol Rhinol (Bord); 1971; 92(11):858-63. PubMed ID: 5151167
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contribution to the treatment of hypacusia, tinnitus and vertigo in patients with arteriosclerotic diseases].
    Cordone G; Ciurlo E
    Minerva Otorinolaringol; 1968; 18(5):255-65. PubMed ID: 5719090
    [No Abstract]   [Full Text] [Related]  

  • 14. [Viral etiology of sudden hearing loss].
    Mitschke H
    Monatsschr Ohrenheilkd Laryngorhinol; 1972; 106(7):326-31. PubMed ID: 5083618
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of peripheral vestibular vertigo--effects of Duvadilan in double blind test].
    Goto K; Okutomi A; Utsunomiya M; Takahashi F
    Jibiinkoka; 1971 May; 43(5):405-11. PubMed ID: 4939297
    [No Abstract]   [Full Text] [Related]  

  • 16. [Massive doses of BTMP (Biotamin) for neurologic hearing disorders].
    Tani I; Miyata S
    Jibiinkoka; 1966 Jul; 38(7):755-7. PubMed ID: 4860028
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of senile hearing disorders and disorders of the inner ear with the geriatric therapeutic agent Kavaform].
    Kluger HA
    Munch Med Wochenschr; 1969 Jun; 111(26):1440-4. PubMed ID: 4897300
    [No Abstract]   [Full Text] [Related]  

  • 18. [Management of threatened abortion and premature delivery with Duvadilan and Dilatol].
    Hengst P; Neumann H
    Z Arztl Fortbild (Jena); 1971 Aug; 65(16):850-4. PubMed ID: 4946946
    [No Abstract]   [Full Text] [Related]  

  • 19. Rationale of vasoexcitor and vasodilator drug therapy in shock.
    Hershey SG
    Proc Inst Med Chic; 1966 May; 26(3):51. PubMed ID: 5936507
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy for hypertension.
    Sherrill EN; Carr AA
    J Med Assoc Ga; 1981 May; 70(5):341-4. PubMed ID: 7264467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.